Note: Aduro BioTech's revenues are gauged from an analysis of company filings.
Aduro BioTech has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
January 5, 2015
Complete list of funding rounds and total amounts in the Company Report
Trademark applications show the products and services that Aduro BioTech is developing and marketing.
Aduro BioTech doesn't have any recent trademark applications, indicating Aduro BioTech is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
ADURO BIOTECH Pharmaceutical preparations, namely, vaccines for use in the field of oncology; pharmaceutical products, in the nature of antibodies, for the treatment of cancer, infectious disease and immune disorders; pharmaceutical products for the treatment of cancer, infectious disease and immune disorders
LADD Pharmaceutical research and development services; medical research and development services in the field of treatments for cancer, infectious diseases, and immune disorders
B-SELECT pharmaceutical products for the treatment of cancer, infectious disease and immune disorders
Determine whether Aduro BioTech grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Aduro BioTech is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Aduro BioTech's Largest Competitors
A competitive analysis shows these companies are in the same general field as Aduro BioTech, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Aduro BioTech.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Aduro BioTech and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.